We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$204B
AUM Growth
+$40.7B
Cap. Flow
+$14.4B
Cap. Flow %
7.02%
Top 10 Hldgs %
15.11%
Holding
4,579
New
569
Increased
2,381
Reduced
1,060
Closed
261

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$845M
2
TME icon
Tencent Music
TME
+$643M
3
BIDU icon
Baidu
BIDU
+$528M
4
TSLA icon
Tesla
TSLA
+$476M
5
AMZN icon
Amazon
AMZN
+$391M

Sector Composition

Rank Sector Weight
1 Technology 13.51%
2 Consumer Discretionary 9.39%
3 Healthcare 9.23%
4 Communication Services 7.28%
5 Financials 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPT
2951
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$1.51M ﹤0.01%
174,922
+22,555
+15% +$152K
DAR icon
2952
CALL
Darling Ingredients
DAR
$9.44B
$1.51M ﹤0.01%
+26,200
New +$1.25M
IAG icon
2953
IAMGOLD
IAG
$10.5B
$1.51M ﹤0.01%
411,955
+57,950
+16% +$213K
KELYA icon
2954
Kelly Services Class A
KELYA
$528M
$1.51M ﹤0.01%
73,408
+41,913
+133% +$840K
TMP icon
2955
Tompkins Financial
TMP
$1.42B
$1.51M ﹤0.01%
21,327
+4,811
+29% +$305K
TRS icon
2956
TriMas Corp
TRS
$1.44B
$1.5M ﹤0.01%
47,491
+16,652
+54% +$456K
PRA
2957
DELISTED
ProAssurance
PRA
$1.5M ﹤0.01%
84,423
+21,621
+34% +$352K
IGMS
2958
DELISTED
IGM Biosciences
IGMS
$1.5M ﹤0.01%
16,998
+4,643
+38% +$326K
BGC icon
2959
BGC Group
BGC
$4.89B
$1.5M ﹤0.01%
374,764
+126,285
+51% +$442K
DDS icon
2960
Dillards
DDS
$9.56B
$1.5M ﹤0.01%
23,767
+528
+2% +$25.8K
PLOW icon
2961
Douglas Dynamics
PLOW
$1.02B
$1.5M ﹤0.01%
35,045
+9,205
+36% +$354K
MODV
2962
DELISTED
ModivCare
MODV
$1.5M ﹤0.01%
10,806
-4,481
-29% -$556K
AXU
2963
DELISTED
Alexco Resource Corp
AXU
$1.49M ﹤0.01%
470,001
-29,999
-6% -$78.8K
OEF icon
2964
iShares S&P 100 ETF
OEF
$20.6B
$1.49M ﹤0.01%
8,676
-92
-1% -$15K
TTMI icon
2965
TTM Technologies
TTMI
$14.5B
$1.49M ﹤0.01%
108,017
+22,937
+27% +$293K
NVEE
2966
DELISTED
NV5 Global
NVEE
$1.49M ﹤0.01%
75,536
+7,756
+11% +$130K
TPCO
2967
DELISTED
Tribune Publishing Company Common Stock
TPCO
$1.49M ﹤0.01%
108,618
+5,985
+6% +$73.8K
ACB
2968
Aurora Cannabis
ACB
$185M
$1.49M ﹤0.01%
17,867
+8,879
+99% +$647K
CELH icon
2969
Celsius Holdings
CELH
$7.03B
$1.49M ﹤0.01%
+88,518
New +$884K
DVAX
2970
DELISTED
Dynavax Technologies
DVAX
$1.48M ﹤0.01%
333,319
-187,902
-36% -$851K
BANF icon
2971
BancFirst
BANF
$3.8B
$1.48M ﹤0.01%
25,137
+4,344
+21% +$223K
GLW icon
2972
CALL
Corning
GLW
$143B
$1.48M ﹤0.01%
41,000
HIPR
2973
DELISTED
Direxion High Growth ETF
HIPR
$1.47M ﹤0.01%
25,000
TFSL icon
2974
TFS Financial
TFSL
$4.93B
$1.47M ﹤0.01%
83,512
+29,222
+54% +$486K
CNS icon
2975
Cohen & Steers
CNS
$4.3B
$1.47M ﹤0.01%
19,774
-1,142
-5% -$75.3K

Similar funds

Credit Suisse's Q4 2020 Portfolio in Review

As of Q4 2020, Credit Suisse held 4,579 positions worth $204B, up 25% from $164B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $14.4B of net new capital in Q4 2020, opening 569 new positions and adding to 2,381 existing holdings. Its largest new stake was Palantir: 6,341,206 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $546M trimmed.

  • Credit Suisse's largest Q4 2020 buy was Palantir: 6,341,206 shares worth $149M.
  • Credit Suisse added most to Alibaba in Q4 2020, an estimated $845M increase.
  • Credit Suisse's biggest Q4 2020 reduction was UnitedHealth, cutting an estimated $546M.
  • Credit Suisse fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $260M.
  • Credit Suisse's ten largest holdings make up 15% of its $204B portfolio in Q4 2020.
  • Credit Suisse opened 569 new positions and closed 261 in Q4 2020.
  • Credit Suisse's portfolio value rose 25% quarter-over-quarter to $204B.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.